Signaturefd, LLC Bristol Myers Squibb CO Transaction History

Signaturefd, LLC

$4.94 Billion
Q1 2025

A detailed history of Signaturefd, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Signaturefd, LLC holds 106,013 shares of BMY stock, worth $4.98 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

106,013

Previous 102,783 3.14%

Holding current value

$4.98 Million

Previous $5.81 Million 11.22%

% of portfolio

0.13%

Previous 0.11%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$53.9 - $63.11 $174,097 - $203,845	3,230 Added 3.14%	106,013 $6.47 Million
Q4 2024 Feb 10, 2025	BUY	$51.92 - $59.94 $187,379 - $216,323	3,609 Added 3.64%	102,783 $5.81 Million
Q3 2024 Oct 21, 2024	BUY	$39.66 - $51.75 $309,308 - $403,598	7,799 Added 8.54%	99,174 $5.13 Million
Q2 2024 Jul 29, 2024	SELL	$40.25 - $52.99 $291,047 - $383,170	-7,231 Reduced 7.33%	91,375 $3.79 Million
Q1 2024 May 03, 2024	SELL	$47.98 - $54.4 $187,074 - $212,105	-3,899 Reduced 3.8%	98,606 $5.35 Million
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $168,758 - $201,375	-3,481 Reduced 3.28%	102,505 $5.26 Million
Q3 2023 Nov 03, 2023	BUY	$57.89 - $64.73 $32,649 - $36,507	564 Added 0.53%	105,986 $6.15 Million
Q2 2023 Aug 01, 2023	SELL	$63.71 - $70.74 $85,307 - $94,720	-1,339 Reduced 1.25%	105,422 $6.74 Million
Q1 2023 Apr 28, 2023	BUY	$65.71 - $74.53 $3.91 Million - $4.44 Million	59,528 Added 126.03%	106,761 $7.4 Million
Q4 2022 Jan 27, 2023	BUY	$68.48 - $81.09 $181,472 - $214,888	2,650 Added 5.94%	47,233 $3.4 Million
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $120 - $71,153	926 Added 2.12%	44,583 $3.17 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $92,953 - $102,374	1,280 Added 3.02%	43,657 $3.36 Million
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $318,097 - $381,427	5,174 Added 13.91%	42,377 $3.1 Million
Q4 2021 Jan 25, 2022	BUY	$53.63 - $62.52 $81,088 - $94,530	1,512 Added 4.24%	37,203 $2.32 Million
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $88,873 - $104,103	-1,502 Reduced 4.04%	35,691 $2.11 Million
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $48,104 - $52,385	777 Added 2.13%	37,193 $2.49 Million
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $216,175 - $243,133	-3,643 Reduced 9.09%	36,416 $2.3 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $131,935 - $149,507	-2,285 Reduced 5.4%	40,059 $2.49 Million
Q3 2020 Nov 03, 2020	BUY	$57.43 - $63.64 $413,151 - $457,826	7,194 Added 20.47%	42,344 $2.55 Million
Q2 2020 Jul 30, 2020	BUY	$54.82 - $64.09 $14,965 - $17,496	273 Added 0.78%	35,150 $2.07 Million
Q1 2020 Apr 23, 2020	BUY	$46.4 - $67.43 $17,678 - $25,690	381 Added 1.1%	34,877 $1.94 Million
Q4 2019 Feb 05, 2020	BUY	$49.21 - $64.19 $741,250 - $966,893	15,063 Added 77.51%	34,496 $2.21 Million
Q3 2019 Oct 16, 2019	BUY	$42.77 - $50.71 $105,214 - $124,746	2,460 Added 14.49%	19,433 $985,000
Q2 2019 Jul 31, 2019	SELL	$44.62 - $49.34 $62,155 - $68,730	-1,393 Reduced 7.58%	16,973 $770,000
Q1 2019 May 09, 2019	SELL	$45.12 - $53.8 $6,271 - $7,478	-139 Reduced 0.75%	18,366 $876,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $11,653 - $15,111	-239 Reduced 1.28%	18,505 $962,000
Q3 2018 Nov 15, 2018	BUY	$55.19 - $62.25 $26,601 - $30,004	482 Added 2.64%	18,744 $1.16 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $59,372 - $74,001	-1,175 Reduced 6.05%	18,262 $1.01 Million
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $72,383 - $83,327	1,208 Added 6.63%	19,437 $1.23 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $196,783 - $214,544	3,283 Added 21.97%	18,229 $1.12 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $55,671 - $64,249	1,008 Added 7.23%	14,946 $953,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,938	13,938 $777,000

Others Institutions Holding BMY

# of Institutions

2,809

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.9B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account